Related Experiment Videos
Ebp1, an ErbB-3 binding protein, interacts with Rb and affects Rb transcriptional regulation
1Greenebaum Cancer Center, University of Maryland, Baltimore, Maryland 21201, USA.
Abstract:
Ebp1, an ErbB-3 binding protein, inhibits the proliferation and induces the differentiation of human breast cancer cells. The mechanisms of these effects are unknown. Rb, the product of the retinoblastoma gene, is an important modulator of cell cycle progression and cellular differentiation. We report that Rb is a binding target for Ebp1. Ebp1 was localized to both the nucleus and the cytoplasm of logarithmically growing AU565 breast cancer cells and HeLa cells as determined by confocal immunofluorescent microscopy. Ebp1 was present in Rb immunoprecipitates derived from AU565 breast cancer cells. GST-Rb also bound endogenous Ebp1. Using GST-Ebp1 constructs, we determined that the 72 C-terminal amino acids of Ebp1 were sufficient to bind Rb. Dephosphorylation of Ebp1 enhanced the interaction of Ebp1 with Rb. The overexpression of Ebp1 in MCF-7 and AU565 (Rb(+)) cells inhibited the activity of the E2F1 regulated cyclin-E promoter. Ebp1 bound E2F1 indirectly via Rb in lysates of MCF-7 cells. The interaction of Ebp1 with Rb may prove to be an important mechanism of Ebp1 induced changes in cell proliferation and differentiation.
Insights
ErbB-3 binding protein 1 (Ebp1) interacts with the retinoblastoma protein (Rb), influencing breast cancer cell proliferation and differentiation. This interaction may explain how Ebp1 affects cancer cell growth.
Area of Science:
- Oncology
- Molecular Biology
- Cell Biology
Background:
- ErbB-3 binding protein 1 (Ebp1) is known to inhibit human breast cancer cell proliferation and induce differentiation.
- The underlying molecular mechanisms for Ebp1's effects on breast cancer cells remain largely unknown.
- The retinoblastoma protein (Rb) is a critical regulator of cell cycle progression and cellular differentiation.
Purpose of the Study:
- To investigate the interaction between Ebp1 and Rb in human breast cancer cells.
- To elucidate the role of this interaction in Ebp1-mediated effects on cell proliferation and differentiation.
Main Methods:
- Confocal immunofluorescent microscopy was used to determine the cellular localization of Ebp1.
- Co-immunoprecipitation assays were performed to assess the binding of Ebp1 to Rb.
- GST pull-down assays with various GST-Ebp1 constructs were employed to identify the Rb-binding domain of Ebp1.
- Reporter assays were conducted to evaluate the effect of Ebp1 overexpression on E2F1-regulated promoter activity.
Main Results:
- Ebp1 was found to bind to Rb.
- Ebp1 localized to both the nucleus and cytoplasm of breast cancer cells (AU565) and HeLa cells.
- The C-terminal 72 amino acids of Ebp1 were sufficient for Rb binding.
- Dephosphorylation of Ebp1 enhanced its interaction with Rb.
- Overexpression of Ebp1 inhibited the E2F1-regulated cyclin-E promoter activity in MCF-7 and AU565 cells.
- Ebp1 was shown to bind E2F1 indirectly through Rb.
Conclusions:
- Ebp1 directly interacts with the retinoblastoma protein (Rb).
- The interaction between Ebp1 and Rb is modulated by Ebp1 phosphorylation status.
- This Ebp1-Rb interaction likely mediates Ebp1's inhibitory effects on breast cancer cell proliferation and its role in differentiation.
- Ebp1 may regulate cell cycle progression by influencing the E2F1/cyclin-E pathway via Rb.